Patent ID: 7427490

Claim:
A method of determining a diagnosis of stroke or cerebral injury in a subject, said method comprising: analyzing a test sample obtained from a subject for the presence or amount of one or more markers selected from the group consisting of adenylate kinase, brain-derived neurotrophic factor, calbindin-D, creatine kinase-BB, glial fibrillary acidic protein, lactate dehydrogenase, myelin basic protein, neural cell adhesion molecule, neuron-specific enolase, neurotrophin-3, one or more isoforms of protein kinase C, proteolipid protein, S-100β, thrombomodulin, and marker(s) related thereto, wherein said test sample is blood, serum, or plasma; analyzing said test sample for the presence or amount of caspase-3 or marker(s) related thereto; and correlating the presence or amount of the analyzed markers to the occurrence or nonoccurrence of a stroke or cerebral injury in said subject.